| HBIOX | VDVIX | HBIOX / VDVIX | |
| Total Expense Ratio | 1.01 | 0.16 | 631% |
| Annual Report Gross Expense Ratio | 1.01 | 0.16 | 631% |
| Fund Existence | 28 years | 13 years | - |
| Gain YTD | -0.462 | 18.205 | -3% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 859M | 324B | 0% |
| Annual Yield % from dividends | 1.46 | 2.37 | 62% |
| Returns for 1 year | 7.80 | 26.29 | 30% |
| Returns for 3 years | 48.06 | 65.27 | 74% |
| Returns for 5 years | 0.91 | 41.50 | 2% |
| Returns for 10 years | 59.21 | 104.73 | 57% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LCMIX | 44.59 | 0.07 | +0.16% |
| ClearBridge Mid Cap Growth IS | |||
| FTASX | 33.94 | 0.01 | +0.03% |
| Fidelity Advisor Asset Manager 70% M | |||
| RYDVX | 2.64 | N/A | N/A |
| Royce Smid-Cap Total Return Service | |||
| BMEAX | 27.50 | -0.09 | -0.33% |
| BlackRock High Equity Income Investor A | |||
| IVFLX | 4.96 | -0.02 | -0.40% |
| Federated Hermes Intl Strat Val Div R6 | |||